Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB.

BMJ. 2000 Jul 22;321(7255):199-204.

2.

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V.

N Engl J Med. 2004 Apr 1;350(14):1387-97.

3.

von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD.

Eur Heart J. 2002 Nov;23(22):1764-70.

PMID:
12419296
4.

Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M.

BMJ. 2000 Jul 22;321(7255):208-13.

5.

Risk factors for coronary heart disease and acute-phase proteins. A population-based study.

Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB.

Eur Heart J. 1999 Jul;20(13):954-9.

PMID:
10361047
6.

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, et al.

BMJ. 1995 Sep 16;311(7007):711-4. Erratum in: BMJ 1995 Oct 14;311(7011):985.

7.

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study.

Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC.

BMJ. 1996 Apr 27;312(7038):1061-5.

8.

Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

Whincup PH, Refsum H, Perry IJ, Morris R, Walker M, Lennon L, Thomson A, Ueland PM, Ebrahim SB.

Heart. 1999 Oct;82(4):448-54.

9.

Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.

Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith GD.

Heart. 2001 Feb;85(2):153-8.

10.

Adiponectin and coronary heart disease: a prospective study and meta-analysis.

Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH.

Circulation. 2006 Aug 15;114(7):623-9. Epub 2006 Aug 7. Erratum in: Circulation. 2007 Mar 13;115(10):e325.

11.

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H.

BMJ. 1990 Dec 1;301(6763):1248-51.

12.

Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD.

Circulation. 2001 May 15;103(19):2323-7.

13.

Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.

Wu T, Rifai N, Willett WC, Rimm EB.

Am J Epidemiol. 2007 Sep 1;166(5):544-51. Epub 2007 Jul 5.

PMID:
17615090
14.

Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.

Sanchez PL, Morinigo JL, Pabon P, Martin F, Piedra I, Palacios IF, Martin-Luengo C.

Heart. 2004 Mar;90(3):264-9.

15.

Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men.

Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M.

Heart. 1996 Jun;75(6):568-72.

16.

Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis.

Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong YK, Zhou X, Ward M.

Eur Heart J. 2002 Mar;23(5):371-5.

PMID:
11846494
17.

Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group.

Circulation. 2005 May 10;111(18):2299-305. Epub 2005 May 2.

18.

Serum iron, infection and inflammation; effects on coronary risk.

Kervinen H, Tenkanen L, Palosuo T, Roivainen M, Manninen V, Mänttäri M.

Scand Cardiovasc J. 2004 Dec;38(6):345-8.

PMID:
15804800
19.

High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study.

Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1385-91. doi: 10.1161/ATVBAHA.107.157164. Epub 2008 Apr 10.

20.

Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men.

Welsh P, Whincup PH, Papacosta O, Wannamethee SG, Lennon L, Thomson A, Rumley A, Lowe GD.

QJM. 2008 Oct;101(10):785-91. doi: 10.1093/qjmed/hcn088. Epub 2008 Aug 1.

PMID:
18676684

Supplemental Content

Support Center